Viewing Study NCT00210834

Home

Certify Doc

Genes

Clinical Trials

CompTox

DrugMatrix

Open Targets

Products

Support

Bugs

Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug

Ignite Creation Date: 2025-12-25 @ 2:19 AM

Ignite Modification Date: 2025-12-26 @ 12:49 AM

Study NCT ID: NCT00210834

Status: COMPLETED

Last Update Posted: 2011-06-10

First Post: 2005-09-13

Is NOT Gene Therapy: False

Has Adverse Events: False

Brief Title: An Efficacy and Safety Study of Epoetin Alfa (PROCRIT) Initiated at 40,000 Units Every Week Versus 80,000 Units Every Two Weeks in Anemic Patients With Cancer Receiving Chemotherapy.

Sponsor: Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

Organization:

Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module